Literature DB >> 23995012

Combination therapy with amphotericin-B and miltefosine for post-kala-azar dermal leishmaniasis: a preliminary report.

Venkat Ramesh1, Kumar Avishek, Vanila Sharma, Poonam Salotra.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23995012     DOI: 10.2340/00015555-1582

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  5 in total

1.  Drug combinations as effective anti-leishmanials against drug resistant Leishmania mexicana.

Authors:  Humera Ahmed; Charlotte R Curtis; Sara Tur-Gracia; Toluwanimi O Olatunji; Katharine C Carter; Roderick A M Williams
Journal:  RSC Med Chem       Date:  2020-07-02

Review 2.  Chemotherapeutics of visceral leishmaniasis: present and future developments.

Authors:  Shyam Sundar; Anup Singh
Journal:  Parasitology       Date:  2017-12-07       Impact factor: 3.234

3.  Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana.

Authors:  Roy Mwenechanya; Julie Kovářová; Nicholas J Dickens; Manikhandan Mudaliar; Pawel Herzyk; Isabel M Vincent; Stefan K Weidt; Karl E Burgess; Richard J S Burchmore; Andrew W Pountain; Terry K Smith; Darren J Creek; Dong-Hyun Kim; Galina I Lepesheva; Michael P Barrett
Journal:  PLoS Negl Trop Dis       Date:  2017-06-16

Review 4.  Post kala-azar dermal leishmaniasis: A threat to elimination program.

Authors:  Mallikarjuna Rao Gedda; Bhawana Singh; Dhiraj Kumar; Abhishek Kumar Singh; Prasoon Madhukar; Shreya Upadhyay; Om Prakash Singh; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2020-07-02

5.  Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.

Authors:  V Ramesh; Himanshu Kaushal; Ashwani Kumar Mishra; Ruchi Singh; Poonam Salotra
Journal:  BMC Public Health       Date:  2015-10-26       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.